Table of Contents
AI Hearing Glasses: Assistive Tech Is Getting Good
AI hearing glasses launched October 1, 2026 at $999, separating voices from noise entirely on-device. Here is the mechanism, the evidence gap and what to ask.
AI hearing glasses are eyewear that amplifies speech and suppresses everything else, and the first serious consumer example arrived on October 1, 2026. Legato launched Legato Frames, starting at $999, with an AI system that distinguishes voices from background noise, amplifies the voices and reduces the rest. No cameras. No recording. All processing happens on the device.
The specification that tells you how much engineering went into it is not the amplification. It is the dual-speaker arrangement that directs sound toward the wearer while cancelling outward sound by 99% within inches of the ear. The person sitting next to you does not hear your hearing aid.
Key Takeaways
- Legato Frames start at $999, weigh 34 grams with lenses, run 10 to 12 hours, come in three styles, support prescription lenses and Bluetooth streaming, and are sold through Legato’s website and select US eye care providers.
- They are eligible for vision insurance coverage, which is a distribution insight rather than a technical one, and possibly the most consequential detail in the announcement.
- The company raised $12 million from Neotribe Ventures, Listen and Village Global. It was founded in 2024 by Mehul Trivedi, who led Bose Frames and then Meta’s Ray-Ban smart glasses at EssilorLuxottica, and Steve Romine, former head of Bose’s hearing aids division and later COO at Audicus.
- No FDA classification and no clinical evidence were reported. The device is described as being for adults with up to moderate hearing loss. That is a meaningful gap and you should ask about it directly.
- The uptake problem is the real story. NIDCD reports that among adults 70 and older with hearing loss who could benefit from hearing aids, fewer than 1 in 3 has ever used them, and among adults 20 to 69, approximately 16%.
What Legato announced
According to Aisha Malik’s October 1, 2026 report for TechCrunch, Legato Frames use an AI-powered system that separates voices from background noise, amplifying speech while reducing unwanted sound. The dual-speaker system directs audio toward the wearer and cancels outward sound by 99% within inches of the ear. All processing occurs on-device, with no cameras and no recording.
The physical specifications: 34 grams with lenses, 10 to 12 hours of battery, three frame styles, prescription lens support, Bluetooth streaming. Distribution runs through Legato’s own website and select US eye care providers, and the frames are eligible for vision insurance coverage.
That insurance line deserves a moment. Hearing aids and eyeglasses sit in different benefit categories, different retail channels and different cultural positions. A device that qualifies as eyewear can reach a person through an optometrist’s office, which is a visit people already make without feeling it is about ageing. Whether or not that was the design intent, it is a serious answer to the uptake problem.
The founding team’s background explains the specification sheet. Mehul Trivedi led Bose Frames and then Meta’s Ray-Ban smart glasses programme at EssilorLuxottica. Steve Romine ran Bose’s hearing aids division and was later COO at Audicus. The company raised $12 million from Neotribe Ventures, Listen and Village Global.
Legato is not alone in the category. At Meta Connect on September 25, 2026, Lucas Ropek reported a hearing-assist device in development for roughly five years, priced at $150, offering focused and omnidirectional amplification modes, against typical hearing aids at around $1,600. Two very different price points, same basic idea.
How speech separation actually works
Three stages, and they stack.
Stage one: spatial filtering. Multiple microphones placed a few centimetres apart receive the same sound at slightly different times. Sound arriving from directly ahead hits all microphones in a predictable pattern; sound from the side arrives with a different delay signature. By adding the microphone signals with carefully chosen delays, a system can make the forward direction add constructively and other directions partially cancel. That is beamforming, and it is pure geometry and arithmetic. It is why a two-microphone device is noticeably worse than a six-microphone one at a restaurant table.
Stage two: neural speech enhancement. Beamforming cannot help when the interfering sound comes from the same direction as the speech, which at a dinner table it constantly does. So a model trained on millions of mixtures of speech and noise learns to estimate, for each frequency band and each short time slice, how much of what it hears is speech. It then applies that estimate as a mask, turning down the bands dominated by noise. This is the part that deserves the “AI” label, and it is the part that has improved dramatically in the last few years.
Stage three: shaping to the ear. Hearing loss is not uniform across frequencies. Most age-related and noise-induced loss is worse at high frequencies, which is where the consonants live, which is why speech becomes mushy before it becomes quiet. So the device applies frequency-dependent gain and compression, ideally fitted to a measured audiogram rather than guessed.
Now the reason all of this has to run locally, which is the detail most coverage misses. The wearer’s ear is not sealed. They hear the direct acoustic sound at the same time as the processed copy from the speaker. If the processed copy arrives measurably later, the two versions interfere and produce a hollow, smeared, comb-filtered sound that is worse than no processing at all. A network round trip to a server takes tens to hundreds of milliseconds. That is catastrophically too slow. On-device processing in a hearing device is not primarily a privacy decision. It is a physics requirement, and the privacy benefit is a very welcome side effect.
What has not been established
I want to be precise here, because this is health technology and families deserve clean lines.
The reporting did not state an FDA classification for Legato Frames, and no clinical evidence was claimed. “Adults with up to moderate hearing loss” is a description of the intended user, self-assessed, rather than a regulatory category.
The regulatory landscape it sits in does have clean lines. The FDA’s over-the-counter hearing aid rule took effect on October 17, 2022, and covers adults aged 18 and older with perceived mild to moderate hearing loss. OTC hearing aids are regulated medical devices that users can fit and adjust themselves, as distinct from prescription hearing aids, which require professional fitting for any severity. The FDA page also notes the stakes plainly: “Using hearing aids may reduce the frequency or severity of cognitive decline, depression, and other health problems in adults.”
So the question to ask Legato, or any company in this category, is a single sentence: is this a regulated hearing aid, or a personal sound amplification product? Both can be useful. They carry different obligations and different evidence requirements, and the answer should not be hard to get.
| Category | Regulatory status | Who it is for | Typical price |
|---|---|---|---|
| Prescription hearing aid | FDA-regulated medical device; professional fitting | Any severity, including severe and profound | Around $1,600 and up per the Meta Connect comparison |
| OTC hearing aid | FDA-regulated since October 17, 2022; self-fitting | Adults 18+, perceived mild to moderate loss | Several hundred dollars upward |
| Personal sound amplification product | Not a hearing aid; for people without hearing loss | Situational amplification | Tens to hundreds of dollars |
| AI hearing glasses (Legato Frames) | Classification not stated in reporting | Adults with up to moderate loss | From $999, vision insurance eligible |
| Hearing-assist glasses (Meta, in development) | Not stated | Not stated | $150 as presented |
| Earbuds with hearing features | Varies; some have cleared hearing-aid features | Varies by product | Bundled with the earbuds |
Why the uptake gap is the actual problem
Hearing assistance has a distribution problem rather than a technology problem, and the numbers are stark.
The NIDCD’s hearing statistics, last updated September 20, 2024, report that among adults aged 70 and older with hearing loss who could benefit from hearing aids, “fewer than 1 in 3 (30%) has ever used them,” and that among adults 20 to 69 who could benefit, approximately 16% have ever used them. Also from NIDCD: among adults 20 to 69 reporting five or more years of exposure to very loud noise at work, about 18% have speech-frequency hearing loss in both ears.
Globally, the WHO fact sheet dated 3 March 2026 reports that over 5% of the world’s population, or 430 million people, require rehabilitation for hearing loss, that around 95.1 million children aged 5 to 19 live with hearing loss, that over 1 billion young adults are at risk of permanent avoidable hearing loss from unsafe listening, and that unaddressed hearing loss costs almost US$1 trillion annually.
Two barriers explain most of that gap: price and stigma. A device sold as eyewear, fitted at an optometrist, covered by vision benefits, attacks the second one directly. A $150 amplification device attacks the first. Neither is a medical breakthrough. Both could move more people into help than a decade of incremental audiology improvement, which is why this is a more important story than the camera-glasses news that got all the attention. We put the category side by side in what smart glasses actually record.
What to do at home
Get the audiogram before you get the device
If anyone in your family is struggling to follow conversation, the first step is a hearing test, not a purchase. A measured audiogram tells you which frequencies are affected and by how much, and every device in the table above works better when fitted to real data than to a self-assessment. It also catches the conditions that need a doctor rather than a gadget.
Ask the one-sentence regulatory question
“Is this a regulated hearing aid or a personal sound amplifier?” Ask it in writing, by email or chat, and keep the answer. It determines what evidence stands behind the product and what recourse you have if it does not work.
Watch your teenager’s listening volume, because the WHO number is about them
Over 1 billion young adults are at risk of permanent, avoidable hearing loss from unsafe listening practices. That is a prevention story and it is entirely in your household’s control. Most phones now show a weekly headphone-volume report; look at it together once and let the number do the arguing.
Treat the no-camera, no-recording design as the feature it is
Legato’s description includes no cameras and no recording, with all processing on-device. In a year when eyewear privacy was the dominant story, an assistive device that captures nothing is worth distinguishing from the products that caused the backlash. The reasoning behind why that is the strongest kind of guarantee is in privacy by subtraction.
Check the insurance angle before the price tag
Vision insurance eligibility can change the effective cost substantially, and it is not something you will discover from a product page. One phone call to your benefits provider is worth more than an hour of comparison shopping. Global access to wearables is its own problem, which we look at in wearable pricing and who actually gets these devices.
What not to do: don’t buy an amplifier for a child without a diagnosis
Amplification without a diagnosis can mask a treatable condition and, at the wrong settings, add to noise exposure. Children’s hearing care runs through audiology for good reasons. The consumer devices in this article are described for adults, and that is not a marketing boundary.
What to Watch For Over the Next 3 Months
- Week 4: Watch for Legato to state a regulatory classification, and for any published clinical or benchtop performance data. A company confident in its speech-in-noise performance will publish a measurement.
- Month 2 red flags: Marketing that implies medical benefit without naming a regulatory pathway, or that quotes a speech-intelligibility improvement without saying how it was measured. Both are common in this category and both are reasons to slow down.
- Month 3 self-check: If someone in your family tried a device, ask the only question that matters: can they follow a conversation at a restaurant table now? Not whether it sounds louder. Whether comprehension improved in the hard situation.
Frequently Asked Questions
What are AI hearing glasses?
Eyeglasses with microphones, speakers and a processor that separate speech from background noise and amplify the speech. Legato Frames, launched October 1, 2026 from $999, use an AI system to distinguish voices from noise, with all processing on-device and no cameras or recording.
Are AI hearing glasses the same as hearing aids?
Not necessarily. Hearing aids, whether prescription or over-the-counter, are FDA-regulated medical devices, with the OTC category established by a rule effective October 17, 2022 for adults 18 and older with perceived mild to moderate loss. The reporting on Legato Frames did not state a regulatory classification, which is the question to ask directly.
Why does the processing have to happen on the device?
Latency. The wearer hears the direct acoustic sound and the processed copy at the same time, and if the processed version arrives measurably later the two interfere and sound worse than no processing. A network round trip takes tens to hundreds of milliseconds, which is far too slow for a hearing device.
How much do they cost?
Legato Frames start at $999 and are eligible for vision insurance coverage. The hearing-assist glasses Meta showed at Connect on September 25, 2026 were presented at $150. For comparison, the same report cited typical hearing aids at around $1,600.
Can my child use these?
The devices discussed here are described for adults. Children’s hearing needs a proper audiological pathway, because amplification without diagnosis can mask a treatable condition and can be set incorrectly. Start with a hearing test.
Why is this a bigger story than camera glasses?
Because the limiting factor in hearing assistance is uptake, not technology. NIDCD reports that fewer than 1 in 3 adults 70 and older who could benefit from hearing aids have ever used them, and approximately 16% of adults 20 to 69. Price and stigma explain most of that, and eyewear framing plus a $150 price point attack both.
About the author
Ricky Flores is the founder of HiWave Makers and an electrical engineer with 15+ years of experience building consumer technology at Apple, Samsung, and Texas Instruments. He writes about how kids learn to build, think, and create in a tech-saturated world. Read more at hiwavemakers.com.
Sources
- Malik, A. (2026, October 1). “Hearing tech startup Legato launches its AI hearing glasses.” TechCrunch. https://techcrunch.com/2026/10/01/hearing-tech-startup-legato-launches-its-ai-hearing-glasses/
- Ropek, L. (2026, September 25). “At Meta Connect, the company’s smart glasses were everywhere.” TechCrunch. https://techcrunch.com/2026/09/25/at-meta-connect-the-companys-smart-glasses-were-everywhere/
- U.S. Food and Drug Administration. “OTC Hearing Aids: What You Should Know.” Rule effective October 17, 2022. https://www.fda.gov/medical-devices/hearing-aids/otc-hearing-aids-what-you-should-know
- National Institute on Deafness and Other Communication Disorders. (Updated 2024, September 20). “Quick Statistics About Hearing.” https://www.nidcd.nih.gov/health/statistics/quick-statistics-hearing
- World Health Organization. (2026, March 3). “Deafness and hearing loss.” WHO Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss
- Perez, S. (2026, September 23). “Meta introduces camera-free AI glasses.” TechCrunch. https://techcrunch.com/2026/09/23/meta-introduces-camera-free-ai-glasses/